Aurealis Therapeutics team visited China from June 9–13, 2025, for a dedicated partnering week. Juha Yrjänheikki (CEO), Laurent Décory (COO), Hanna-Riikka Kärkkäinen (Director, Quality & Regulatory Affairs), and Jere Kurkipuro (Director, Pre-clinical & Pharmacology) met with investors, scientific partners, and licensing stakeholders to explore new collaboration opportunities.
Biotech Week Boston 2025
Aurealis Therapeutics CEO, Juha Yrjänheikki, and COO, Laurent Décory, will be attending the Biotech Week Boston from 15-18 September 2025 in Boston, USA.